Current Report Filing (8-k)
04 December 2019 - 4:53AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): December 2, 2019
QUORUM HEALTH CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-37550
|
|
47-4725208
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
file number)
|
|
(IRS Employer
Identification No.)
|
1573 Mallory Lane
Brentwood, Tennessee 37027
(Address of principal executive offices) (Zip Code)
|
Registrants Telephone Number, Including Area Code: (615)
221-1400
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, $0.0001 par value per share
|
|
QHC
|
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the
Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events
On December 2, 2019, Quorum Health Corporation (the Company) issued a press release (the Press Release) confirming
the receipt of a non-binding proposal letter from KKR Credit Advisors (US) LLC relating to a potential recapitalization transaction, potentially including, among other things a buy-out of the public shares held by minority holders at a price of $1.00 per share. A copy of the Press Release is attached as Exhibit 99.1 and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
QUORUM HEALTH CORPORATION
(registrant)
|
|
|
By:
|
|
/s/ Alfred Lumsdaine
|
|
|
Alfred Lumsdaine
|
|
|
Executive Vice President
|
|
|
and Chief Financial Officer
(principal
financial officer)
|
Date: December 3, 2019
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Sep 2023 to Sep 2024
Real-Time news about Quorum Health Corporation (New York Stock Exchange): 0 recent articles
More Quorum Health Corp News Articles